https://www.selleckchem.com/pr....oducts/disodium-r-2-
In this paper, we present a systematic review where we compare the current evidence of two options for treatment in fragile population SBRT and VATS. Radiotherapy (RT) plays a key role in the control of locally advanced non-small cell lung cancer (LA-NSCLC). Throughout the years, different doses and fractionations of RT have been used in an attempt to optimize the results. Recently, special interest has been given to hypofractionation (hypoRT) and stereotactic body radiation therapy (SBRT). HypoRT is a relatively w
Like
Comment
Share
